Spend Distribution
| Campaign | Spend | Clicks | Impr. | Leads | CTR | CPC | CPA |
|---|---|---|---|---|---|---|---|
| Search | Website Form Submission | $22,197.70 | 5,647 | 104,009 | 1,124 | 5.43% | $3.93 | $19.75 |
| PMax | General #2 | $13,148.20 | 5,150 | 234,141 | 364 | 2.2% | $2.55 | $36.09 |
| PMax | General | NEW SITE | $12,614.58 | 5,030 | 103,135 | 897 | 4.88% | $2.51 | $14.07 |
| PMax | General | $1,437.44 | 626 | 18,585 | 10 | 3.37% | $2.30 | $151.31 |
| Demand Gen - 2026-07-10 | $909.91 | 299 | 27,888 | 12 | 1.07% | $3.04 | $75.83 |
| Total | $50,307.83 | 16,752 | 487,758 | 2,407 | 3.43% | $3.00 | $20.90 |
| Campaign | Spend | Clicks | Impr. | Conv. | CTR | CPC | CPA |
|---|---|---|---|---|---|---|---|
| Bad DOB Match | Sales Campaign [Suggestion] | $5,355.66 | 4,850 | 147,952 | 249 | 3.28% | $1.10 | $21.51 |
| HMO Match | Sales Campaign [Look Alike] | $3,707.69 | 3,360 | 128,011 | 182 | 2.62% | $1.10 | $20.37 |
| General | Sales Campaign V3 | $1,731.47 | 3,429 | 102,126 | 209 | 3.36% | $0.50 | $8.28 |
| Just Turned of Age Match | Sales Campaign [Suggestion] | $1,723.93 | 1,202 | 40,429 | 67 | 2.97% | $1.43 | $25.73 |
| HMO Match | Sales Campaign [No Suggestion] | $943.57 | 372 | 17,802 | 26 | 2.09% | $2.54 | $36.29 |
| Total | $13,462.32 | 13,213 | 436,320 | 733 | 3.03% | $1.02 | $18.37 |
Key Insight: From May through August, MM achieved the lowest patient CPA, dropping to $510.77 in August. The "In Chase" and "Patients" stages are the two most critical qualification milestones, and MM has consistently improved cost-efficiency in both.
MM (Melleka Marketing) Monthly Performance
| Month | Total Spend | Patients | Patient CPA | In Chase | Cost / In Chase | Cost / (In Chase + Patients) |
|---|---|---|---|---|---|---|
| May | $12,735.66 | 23 | $553.72 | 6 | $2,122.61 | $439.16 |
| June | $18,659.90 | 22 | $848.18 | 17 | $1,097.64 | $478.46 |
| July | $17,266.53 | 25 | $690.66 | 31 | $556.98 | $308.33 |
| August | $14,812.35 | 29 | $510.77 | 41 | $361.28 | $247.91 |
Helix Monthly Performance
| Month | Total Spend | Patients | Patient CPA | In Chase | Cost / In Chase | Cost / (In Chase + Patients) |
|---|---|---|---|---|---|---|
| May | $36,128.00 | 57 | $633.82 | 25 | $1,445.12 | $440.59 |
| June | $27,600.00 | 53 | $520.75 | 58 | $475.86 | $248.65 |
| July | $54,779.00 | 58 | $944.47 | 74 | $740.26 | $414.99 |
| August | $37,195.00 | 43 | $865.00 | 70 | $531.36 | $389.48 |
Head-to-Head: May - August 2026
| Metric | MM (Melleka) | Helix | Difference |
|---|---|---|---|
| Total Spend | $63,474 | $155,702 | MM spent 59% less |
| Total Patients | 99 | 211 | Helix: 2.1x volume |
| Patient CPA (Aug) | $510.77 | $865.00 | MM 41% lower |
| Total In Chase | 95 | 227 | Helix: 2.4x volume |
| Cost / (In Chase + Patients) (Aug) | $247.91 | $389.48 | MM 36% lower |
| July Patient CPA | $690.66 | $944.47 | MM 27% lower |
May
June
July
August ⭐
August Result: MM is acquiring patients at $510.77 per patient compared to Helix at $865.00. That is a 41% lower cost per patient. MM's combined In Chase + Patient cost is $247.91 vs Helix at $389.48 (36% lower). The trend shows MM's efficiency has improved every month from May through August while spending significantly less overall.
| Month | Spend | Patients | Patient CPA | In Chase | Cost/(IC+P) |
|---|---|---|---|---|---|
| October | $18,488.00 | 4 | $4,622.00 | 2 | $3,081.33 |
| November | $43,888.00 | 12 | $3,657.33 | 1 | $3,376.00 |
| December | $30,122.25 | 35 | $860.64 | 4 | $772.37 |
| January | $52,753.02 | 53 | $995.34 | 31 | $628.01 |
| February | $12,427.53 | 7 | $1,775.36 | 14 | $591.79 |
| March | $11,776.43 | 18 | $654.25 | 0 | $654.25 |
| April | $14,843.64 | 12 | $1,236.97 | 8 | $742.18 |
| May | $12,735.66 | 23 | $553.72 | 6 | $439.16 |
| June | $18,659.90 | 22 | $848.18 | 17 | $478.46 |
| July | $17,266.53 | 25 | $690.66 | 31 | $308.33 |
| August | $14,812.35 | 29 | $510.77 | 41 | $247.91 |
The Story: MM started at a $4,622 patient CPA in October 2025. Through continuous optimization, that number has dropped to $510.77 in August 2026, an 89% reduction. Meanwhile, "In Chase" leads (the stage right before becoming a patient) have surged from 2 per month to 41 in August, indicating a strong pipeline of near-conversions.